Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 3
Results: 12
Correction to: Ocular Toxicity of Targeted Anticancer Agents.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Authors' Reply to Mazza et al.: "Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence".
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Efgartigimod: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 341, doi. 10.1007/s40265-022-01678-3
- By:
- Publication type:
- Article
Maribavir: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 335, doi. 10.1007/s40265-022-01677-4
- By:
- Publication type:
- Article
Pharmacologic Management of Persistent Pain in Cancer Survivors.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 275, doi. 10.1007/s40265-022-01675-6
- By:
- Publication type:
- Article
Ocrelizumab: A Review in Multiple Sclerosis.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 323, doi. 10.1007/s40265-022-01672-9
- By:
- Publication type:
- Article
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 251, doi. 10.1007/s40265-021-01670-3
- By:
- Publication type:
- Article
Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 293, doi. 10.1007/s40265-021-01668-x
- By:
- Publication type:
- Article
Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 241, doi. 10.1007/s40265-021-01667-y
- By:
- Publication type:
- Article
Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 311, doi. 10.1007/s40265-021-01665-0
- By:
- Publication type:
- Article
Efgartigimod: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 3, p. 341, doi. 10.1007/s40265-022-01678-3
- By:
- Publication type:
- Article